Undre NA and Schäfer A |
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. |
1998 |
Transplant. Proc. |
pmid:9636512
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
Smoter P et al. |
Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. |
2014 |
Transplant. Proc. |
pmid:25380918
|
Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Abou-Jaoude MM et al. |
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients. |
2003 |
Transplant. Proc. |
pmid:14612103
|
Park K et al. |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study. |
2000 |
Transplant. Proc. |
pmid:11119901
|
Lane BC et al. |
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679829
|
Christians U et al. |
High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721262
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Brook NR et al. |
Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamune. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808577
|
Shitrit D et al. |
Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient. |
2003 |
Transplant. Proc. |
pmid:12644073
|
Cadoff EM et al. |
Assay of FK 506 in plasma. |
1990 |
Transplant. Proc. |
pmid:1689898
|
Crespo-Leiro MG et al. |
Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy. |
2002 |
Transplant. Proc. |
pmid:11959213
|
Ringe B et al. |
Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept. |
1998 |
Transplant. Proc. |
pmid:9636573
|
Tashiro H et al. |
Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats. |
2000 |
Transplant. Proc. |
pmid:11120201
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
Jurewicz WA |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report. |
1999 |
Transplant. Proc. |
pmid:10576048
|
Schreiber SL et al. |
Immunophilin-ligand complexes as probes of intracellular signaling pathways. |
1991 |
Transplant. Proc. |
pmid:1721293
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Liu M et al. |
C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. |
2004 |
Transplant. Proc. |
pmid:15518760
|
Boran M et al. |
Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. |
2014 |
Transplant. Proc. |
pmid:24935296
|
Butt TR et al. |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506. |
1996 |
Transplant. Proc. |
pmid:8623486
|
Burg M et al. |
Enteric-coated mycophenolate sodium reduces gastrointestinal symptoms in renal transplant patients. |
2009 |
Transplant. Proc. |
pmid:20005359
|
Yamazaki R et al. |
Interindividual variation of maximal blood levels of tacrolimus after its oral administration in hematopoietic cell transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19545738
|
Laftavi MR et al. |
African American renal transplant recipients (RTR) require higher tacrolimus doses to achieve target levels compared to white RTR: does clotrimazole help? |
2013 |
Transplant. Proc. |
pmid:24314941
|
Marente VC et al. |
Modigraf administration through jejunostomy in liver transplant recipient: case report. |
2013 |
Transplant. Proc. |
pmid:24314992
|
Niederstadt C et al. |
Effect of FK506 on magnesium homeostasis after renal transplantation. |
1997 |
Transplant. Proc. |
pmid:9365709
|
Foroncewicz B et al. |
Anti-CD25 and tacrolimus therapy may not prevent early primary biliary cirrhosis recurrence after liver transplantation: two case reports. |
2003 |
Transplant. Proc. |
pmid:14529924
|
Reggiani P et al. |
A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919435
|
Vischi S et al. |
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518143
|
Bahra M et al. |
Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. |
2005 |
Transplant. Proc. |
pmid:15919436
|
Kim SW et al. |
Decreased formation of nitric oxide in rats treated with FK506. |
2003 |
Transplant. Proc. |
pmid:12591357
|
Ricordi C et al. |
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. |
1992 |
Transplant. Proc. |
pmid:1376512
|
Vargas V et al. |
Alpha-interferon for acute hepatitis C in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533374
|
Ge J et al. |
Impact of FOXP3 Polymorphisms on the Blood Level of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569929
|
Kapturczak MH et al. |
Pharmacology of calcineurin antagonists. |
2004 |
Transplant. Proc. |
pmid:15041303
|
Cooper MH et al. |
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. |
1991 |
Transplant. Proc. |
pmid:1721326
|
Maes BD and Vanrenterghem YF |
Cyclosporine: advantages versus disadvantages vis-Ã -vis tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15041305
|
Yang SS et al. |
A single center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single). |
2015 |
Transplant. Proc. |
pmid:25891697
|
Hranjec T et al. |
Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report. |
2008 |
Transplant. Proc. |
pmid:18589195
|
Malireddy SR et al. |
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. |
2008 |
Transplant. Proc. |
pmid:18589198
|
Jonas S et al. |
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-up. |
2002 |
Transplant. Proc. |
pmid:12176459
|
Tsuchida Y et al. |
Vascularized bone marrow allotransplantation in rats prolongs a simultaneous skin allograft. |
1997 |
Transplant. Proc. |
pmid:9142252
|
Costa A et al. |
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. |
1997 |
Transplant. Proc. |
pmid:9142281
|
Zegarska J et al. |
Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496443
|
Woodside KJ et al. |
Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile. |
2005 |
Transplant. Proc. |
pmid:15919491
|
Winkler M et al. |
Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. |
1995 |
Transplant. Proc. |
pmid:7533433
|
Sakamoto K et al. |
Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. |
1995 |
Transplant. Proc. |
pmid:7533434
|
Van Thiel DH et al. |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721357
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721358
|
Barten MJ et al. |
Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12270442
|
Nalesnik MA et al. |
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. |
1991 |
Transplant. Proc. |
pmid:1703335
|
Yoshimura N et al. |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176501
|
Ribes D et al. |
Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182816
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Reichenspurner H et al. |
Tacrolimus-based immunosuppressive protocols in lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083062
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Khanna A et al. |
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123118
|
Alper G and Small SL |
Cerebrospinal fluid after organ transplantation. |
1996 |
Transplant. Proc. |
pmid:8908142
|
Takagishi K et al. |
Effects of FK-506 on collagen arthritis in mice. |
1989 |
Transplant. Proc. |
pmid:2468205
|
Schmidt RJ et al. |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721390
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Ierardi E et al. |
Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. |
2001 |
Transplant. Proc. |
pmid:11377467
|
Jørgensen KA et al. |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176551
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Park JW et al. |
Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report. |
2011 Jul-Aug |
Transplant. Proc. |
pmid:21839284
|
Chang HR et al. |
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients. |
2007 |
Transplant. Proc. |
pmid:17580178
|
Mor E et al. |
Homocysteine levels among transplant recipients: effect of immunosuppressive protocols. |
2001 |
Transplant. Proc. |
pmid:11543802
|
Kokado Y et al. |
Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083515
|
Weinbroum AA et al. |
Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. |
2001 |
Transplant. Proc. |
pmid:11543812
|
Zuckermann A et al. |
Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083518
|
Ohdan H et al. |
Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123589
|
Meloni F et al. |
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. |
2003 |
Transplant. Proc. |
pmid:12826211
|
Soran A et al. |
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. |
2000 |
Transplant. Proc. |
pmid:10812157
|
Cooper MH et al. |
Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721421
|
Yoshida Y et al. |
Effect of lipoprostaglandin E1 in concordant xenografts. |
1996 |
Transplant. Proc. |
pmid:8658716
|
Formica RN et al. |
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12742475
|
Tahir W et al. |
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. |
|
Transplant. Proc. |
pmid:25645795
|
Baran DA et al. |
Can initial tacrolimus trough levels be predicted from clinical variables? |
2004 |
Transplant. Proc. |
pmid:15621157
|
Hasegawa A et al. |
Optimal use of tacrolimus in living donor renal transplantation in children. |
2002 |
Transplant. Proc. |
pmid:12176635
|
El-Safa EA et al. |
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. |
2006 |
Transplant. Proc. |
pmid:17175263
|
Kovarik JM et al. |
Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus. |
2006 |
Transplant. Proc. |
pmid:17175302
|
van den Berg AP et al. |
Prediction of the inhibition of IL-2 production by calcineurin inhibitors. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267197
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Otto C et al. |
Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats. |
1998 |
Transplant. Proc. |
pmid:9723426
|
Chen H et al. |
Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse. |
1998 |
Transplant. Proc. |
pmid:9745497
|
Ott R et al. |
Does conversion of immunosuppressive monotherapy from cyclosporine A to tacrolimus improve bone mineral density in long-term stable liver transplant recipients? |
2003 |
Transplant. Proc. |
pmid:14697971
|
Thomson AW et al. |
Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. |
1991 |
Transplant. Proc. |
pmid:1721452
|
Mohsin N et al. |
Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics? |
2005 |
Transplant. Proc. |
pmid:16213259
|
Sainsbury TS et al. |
Differential effects of FK 506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata. |
1991 |
Transplant. Proc. |
pmid:1721453
|
Todo S et al. |
Effect of FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450416
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Abe T et al. |
Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. |
2014 |
Transplant. Proc. |
pmid:24767367
|
Li S et al. |
Intrathymic inoculation of donor bone marrow at the time of transplantation plus a short course of tacrolimus induce long-term acceptance to rat lung allografts. |
1998 |
Transplant. Proc. |
pmid:9636431
|
Yoshimura R et al. |
A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450. |
1991 |
Transplant. Proc. |
pmid:1703686
|
Hartwig T et al. |
Low-dose sirolimus and tacrolimus in kidney transplantation: first results of a single-center experience. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750383
|
Pridöhl O et al. |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750384
|